The global market for Live Attenuated Varicella Vaccine is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Live Attenuated Varicella Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Live Attenuated Varicella Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Live Attenuated Varicella Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Live Attenuated Varicella Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Live Attenuated Varicella Vaccine players cover MerckVaccines, GSK, BCHT, Changsheng Bioscience and Keygen Biological, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Live Attenuated Varicella Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Live Attenuated Varicella Vaccine market, with both quantitative and qualitative data, to help readers understand how the Live Attenuated Varicella Vaccine market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Live Attenuated Varicella Vaccine market and forecasts the market size by Type (Monovalent Vaccine and Combination Vaccine,), by Application (Kids Injection and Adults Injection.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Monovalent Vaccine
Combination Vaccine
Segmentation by application
Kids Injection
Adults Injection
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
MerckVaccines
GSK
BCHT
Changsheng Bioscience
Keygen Biological
GC Biopharma
Biken
ChangChun High & New Technology
Sinovac
Chapter Introduction
Chapter 1: Scope of Live Attenuated Varicella Vaccine, Research Methodology, etc.
Chapter 2: Executive Summary, global Live Attenuated Varicella Vaccine market size (sales and revenue) and CAGR, Live Attenuated Varicella Vaccine market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Live Attenuated Varicella Vaccine sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Live Attenuated Varicella Vaccine sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Live Attenuated Varicella Vaccine market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including MerckVaccines, GSK, BCHT, Changsheng Bioscience, Keygen Biological, GC Biopharma, Biken, ChangChun High & New Technology and Sinovac, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Live Attenuated Varicella Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Live Attenuated Varicella Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Live Attenuated Varicella Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Live Attenuated Varicella Vaccine Segment by Type
2.2.1 Monovalent Vaccine
2.2.2 Combination Vaccine
2.3 Live Attenuated Varicella Vaccine Sales by Type
2.3.1 Global Live Attenuated Varicella Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Live Attenuated Varicella Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Live Attenuated Varicella Vaccine Sale Price by Type (2017-2022)
2.4 Live Attenuated Varicella Vaccine Segment by Application
2.4.1 Kids Injection
2.4.2 Adults Injection
2.5 Live Attenuated Varicella Vaccine Sales by Application
2.5.1 Global Live Attenuated Varicella Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Live Attenuated Varicella Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Live Attenuated Varicella Vaccine Sale Price by Application (2017-2022)
3 Global Live Attenuated Varicella Vaccine by Company
3.1 Global Live Attenuated Varicella Vaccine Breakdown Data by Company
3.1.1 Global Live Attenuated Varicella Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Live Attenuated Varicella Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Live Attenuated Varicella Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Live Attenuated Varicella Vaccine Revenue by Company (2020-2022)
3.2.2 Global Live Attenuated Varicella Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Live Attenuated Varicella Vaccine Sale Price by Company
3.4 Key Manufacturers Live Attenuated Varicella Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Live Attenuated Varicella Vaccine Product Location Distribution
3.4.2 Players Live Attenuated Varicella Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Live Attenuated Varicella Vaccine by Geographic Region
4.1 World Historic Live Attenuated Varicella Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Live Attenuated Varicella Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Live Attenuated Varicella Vaccine Annual Revenue by Geographic Region
4.2 World Historic Live Attenuated Varicella Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Live Attenuated Varicella Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Live Attenuated Varicella Vaccine Annual Revenue by Country/Region
4.3 Americas Live Attenuated Varicella Vaccine Sales Growth
4.4 APAC Live Attenuated Varicella Vaccine Sales Growth
4.5 Europe Live Attenuated Varicella Vaccine Sales Growth
4.6 Middle East & Africa Live Attenuated Varicella Vaccine Sales Growth
5 Americas
5.1 Americas Live Attenuated Varicella Vaccine Sales by Country
5.1.1 Americas Live Attenuated Varicella Vaccine Sales by Country (2017-2022)
5.1.2 Americas Live Attenuated Varicella Vaccine Revenue by Country (2017-2022)
5.2 Americas Live Attenuated Varicella Vaccine Sales by Type
5.3 Americas Live Attenuated Varicella Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Live Attenuated Varicella Vaccine Sales by Region
6.1.1 APAC Live Attenuated Varicella Vaccine Sales by Region (2017-2022)
6.1.2 APAC Live Attenuated Varicella Vaccine Revenue by Region (2017-2022)
6.2 APAC Live Attenuated Varicella Vaccine Sales by Type
6.3 APAC Live Attenuated Varicella Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Live Attenuated Varicella Vaccine by Country
7.1.1 Europe Live Attenuated Varicella Vaccine Sales by Country (2017-2022)
7.1.2 Europe Live Attenuated Varicella Vaccine Revenue by Country (2017-2022)
7.2 Europe Live Attenuated Varicella Vaccine Sales by Type
7.3 Europe Live Attenuated Varicella Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Live Attenuated Varicella Vaccine by Country
8.1.1 Middle East & Africa Live Attenuated Varicella Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Live Attenuated Varicella Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Live Attenuated Varicella Vaccine Sales by Type
8.3 Middle East & Africa Live Attenuated Varicella Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Live Attenuated Varicella Vaccine
10.3 Manufacturing Process Analysis of Live Attenuated Varicella Vaccine
10.4 Industry Chain Structure of Live Attenuated Varicella Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Live Attenuated Varicella Vaccine Distributors
11.3 Live Attenuated Varicella Vaccine Customer
12 World Forecast Review for Live Attenuated Varicella Vaccine by Geographic Region
12.1 Global Live Attenuated Varicella Vaccine Market Size Forecast by Region
12.1.1 Global Live Attenuated Varicella Vaccine Forecast by Region (2023-2028)
12.1.2 Global Live Attenuated Varicella Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Live Attenuated Varicella Vaccine Forecast by Type
12.7 Global Live Attenuated Varicella Vaccine Forecast by Application
13 Key Players Analysis
13.1 MerckVaccines
13.1.1 MerckVaccines Company Information
13.1.2 MerckVaccines Live Attenuated Varicella Vaccine Product Offered
13.1.3 MerckVaccines Live Attenuated Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 MerckVaccines Main Business Overview
13.1.5 MerckVaccines Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Live Attenuated Varicella Vaccine Product Offered
13.2.3 GSK Live Attenuated Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 BCHT
13.3.1 BCHT Company Information
13.3.2 BCHT Live Attenuated Varicella Vaccine Product Offered
13.3.3 BCHT Live Attenuated Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 BCHT Main Business Overview
13.3.5 BCHT Latest Developments
13.4 Changsheng Bioscience
13.4.1 Changsheng Bioscience Company Information
13.4.2 Changsheng Bioscience Live Attenuated Varicella Vaccine Product Offered
13.4.3 Changsheng Bioscience Live Attenuated Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Changsheng Bioscience Main Business Overview
13.4.5 Changsheng Bioscience Latest Developments
13.5 Keygen Biological
13.5.1 Keygen Biological Company Information
13.5.2 Keygen Biological Live Attenuated Varicella Vaccine Product Offered
13.5.3 Keygen Biological Live Attenuated Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Keygen Biological Main Business Overview
13.5.5 Keygen Biological Latest Developments
13.6 GC Biopharma
13.6.1 GC Biopharma Company Information
13.6.2 GC Biopharma Live Attenuated Varicella Vaccine Product Offered
13.6.3 GC Biopharma Live Attenuated Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 GC Biopharma Main Business Overview
13.6.5 GC Biopharma Latest Developments
13.7 Biken
13.7.1 Biken Company Information
13.7.2 Biken Live Attenuated Varicella Vaccine Product Offered
13.7.3 Biken Live Attenuated Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Biken Main Business Overview
13.7.5 Biken Latest Developments
13.8 ChangChun High & New Technology
13.8.1 ChangChun High & New Technology Company Information
13.8.2 ChangChun High & New Technology Live Attenuated Varicella Vaccine Product Offered
13.8.3 ChangChun High & New Technology Live Attenuated Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 ChangChun High & New Technology Main Business Overview
13.8.5 ChangChun High & New Technology Latest Developments
13.9 Sinovac
13.9.1 Sinovac Company Information
13.9.2 Sinovac Live Attenuated Varicella Vaccine Product Offered
13.9.3 Sinovac Live Attenuated Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Sinovac Main Business Overview
13.9.5 Sinovac Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Live Attenuated Varicella Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Live Attenuated Varicella Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Monovalent Vaccine
Table 4. Major Players of Combination Vaccine
Table 5. Global Live Attenuated Varicella Vaccine Sales by Type (2017-2022) & (K Units)
Table 6. Global Live Attenuated Varicella Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Live Attenuated Varicella Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Live Attenuated Varicella Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Live Attenuated Varicella Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Live Attenuated Varicella Vaccine Sales by Application (2017-2022) & (K Units)
Table 11. Global Live Attenuated Varicella Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Live Attenuated Varicella Vaccine Revenue by Application (2017-2022)
Table 13. Global Live Attenuated Varicella Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Live Attenuated Varicella Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Live Attenuated Varicella Vaccine Sales by Company (2020-2022) & (K Units)
Table 16. Global Live Attenuated Varicella Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Live Attenuated Varicella Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Live Attenuated Varicella Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Live Attenuated Varicella Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Live Attenuated Varicella Vaccine Producing Area Distribution and Sales Area
Table 21. Players Live Attenuated Varicella Vaccine Products Offered
Table 22. Live Attenuated Varicella Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Live Attenuated Varicella Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Live Attenuated Varicella Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Live Attenuated Varicella Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Live Attenuated Varicella Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Live Attenuated Varicella Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Live Attenuated Varicella Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Live Attenuated Varicella Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Live Attenuated Varicella Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Live Attenuated Varicella Vaccine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Live Attenuated Varicella Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Live Attenuated Varicella Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Live Attenuated Varicella Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Live Attenuated Varicella Vaccine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Live Attenuated Varicella Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Live Attenuated Varicella Vaccine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Live Attenuated Varicella Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Live Attenuated Varicella Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Live Attenuated Varicella Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Live Attenuated Varicella Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Live Attenuated Varicella Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Live Attenuated Varicella Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Live Attenuated Varicella Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Live Attenuated Varicella Vaccine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Live Attenuated Varicella Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Live Attenuated Varicella Vaccine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Live Attenuated Varicella Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Live Attenuated Varicella Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Live Attenuated Varicella Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Live Attenuated Varicella Vaccine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Live Attenuated Varicella Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Live Attenuated Varicella Vaccine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Live Attenuated Varicella Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Live Attenuated Varicella Vaccine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Live Attenuated Varicella Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Live Attenuated Varicella Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Live Attenuated Varicella Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Live Attenuated Varicella Vaccine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Live Attenuated Varicella Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Live Attenuated Varicella Vaccine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Live Attenuated Varicella Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Live Attenuated Varicella Vaccine
Table 66. Key Market Challenges & Risks of Live Attenuated Varicella Vaccine
Table 67. Key Industry Trends of Live Attenuated Varicella Vaccine
Table 68. Live Attenuated Varicella Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Live Attenuated Varicella Vaccine Distributors List
Table 71. Live Attenuated Varicella Vaccine Customer List
Table 72. Global Live Attenuated Varicella Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Live Attenuated Varicella Vaccine Sales Market Forecast by Region
Table 74. Global Live Attenuated Varicella Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Live Attenuated Varicella Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Live Attenuated Varicella Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Live Attenuated Varicella Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Live Attenuated Varicella Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Live Attenuated Varicella Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Live Attenuated Varicella Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Live Attenuated Varicella Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Live Attenuated Varicella Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Live Attenuated Varicella Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Live Attenuated Varicella Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Live Attenuated Varicella Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Live Attenuated Varicella Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Live Attenuated Varicella Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Live Attenuated Varicella Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Live Attenuated Varicella Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Live Attenuated Varicella Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Live Attenuated Varicella Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. MerckVaccines Basic Information, Live Attenuated Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. MerckVaccines Live Attenuated Varicella Vaccine Product Offered
Table 94. MerckVaccines Live Attenuated Varicella Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. MerckVaccines Main Business
Table 96. MerckVaccines Latest Developments
Table 97. GSK Basic Information, Live Attenuated Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. GSK Live Attenuated Varicella Vaccine Product Offered
Table 99. GSK Live Attenuated Varicella Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. GSK Main Business
Table 101. GSK Latest Developments
Table 102. BCHT Basic Information, Live Attenuated Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. BCHT Live Attenuated Varicella Vaccine Product Offered
Table 104. BCHT Live Attenuated Varicella Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. BCHT Main Business
Table 106. BCHT Latest Developments
Table 107. Changsheng Bioscience Basic Information, Live Attenuated Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Changsheng Bioscience Live Attenuated Varicella Vaccine Product Offered
Table 109. Changsheng Bioscience Live Attenuated Varicella Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Changsheng Bioscience Main Business
Table 111. Changsheng Bioscience Latest Developments
Table 112. Keygen Biological Basic Information, Live Attenuated Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Keygen Biological Live Attenuated Varicella Vaccine Product Offered
Table 114. Keygen Biological Live Attenuated Varicella Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Keygen Biological Main Business
Table 116. Keygen Biological Latest Developments
Table 117. GC Biopharma Basic Information, Live Attenuated Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. GC Biopharma Live Attenuated Varicella Vaccine Product Offered
Table 119. GC Biopharma Live Attenuated Varicella Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. GC Biopharma Main Business
Table 121. GC Biopharma Latest Developments
Table 122. Biken Basic Information, Live Attenuated Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Biken Live Attenuated Varicella Vaccine Product Offered
Table 124. Biken Live Attenuated Varicella Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Biken Main Business
Table 126. Biken Latest Developments
Table 127. ChangChun High & New Technology Basic Information, Live Attenuated Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. ChangChun High & New Technology Live Attenuated Varicella Vaccine Product Offered
Table 129. ChangChun High & New Technology Live Attenuated Varicella Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. ChangChun High & New Technology Main Business
Table 131. ChangChun High & New Technology Latest Developments
Table 132. Sinovac Basic Information, Live Attenuated Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Sinovac Live Attenuated Varicella Vaccine Product Offered
Table 134. Sinovac Live Attenuated Varicella Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Sinovac Main Business
Table 136. Sinovac Latest Developments
List of Figures
Figure 1. Picture of Live Attenuated Varicella Vaccine
Figure 2. Live Attenuated Varicella Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Live Attenuated Varicella Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Live Attenuated Varicella Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Live Attenuated Varicella Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Monovalent Vaccine
Figure 10. Product Picture of Combination Vaccine
Figure 11. Global Live Attenuated Varicella Vaccine Sales Market Share by Type in 2021
Figure 12. Global Live Attenuated Varicella Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Live Attenuated Varicella Vaccine Consumed in Kids Injection
Figure 14. Global Live Attenuated Varicella Vaccine Market: Kids Injection (2017-2022) & (K Units)
Figure 15. Live Attenuated Varicella Vaccine Consumed in Adults Injection
Figure 16. Global Live Attenuated Varicella Vaccine Market: Adults Injection (2017-2022) & (K Units)
Figure 17. Global Live Attenuated Varicella Vaccine Sales Market Share by Application (2017-2022)
Figure 18. Global Live Attenuated Varicella Vaccine Revenue Market Share by Application in 2021
Figure 19. Live Attenuated Varicella Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Live Attenuated Varicella Vaccine Revenue Market Share by Company in 2021
Figure 21. Global Live Attenuated Varicella Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Live Attenuated Varicella Vaccine Revenue Market Share by Geographic Region in 2021
Figure 23. Global Live Attenuated Varicella Vaccine Sales Market Share by Region (2017-2022)
Figure 24. Global Live Attenuated Varicella Vaccine Revenue Market Share by Country/Region in 2021
Figure 25. Americas Live Attenuated Varicella Vaccine Sales 2017-2022 (K Units)
Figure 26. Americas Live Attenuated Varicella Vaccine Revenue 2017-2022 ($ Millions)
Figure 27. APAC Live Attenuated Varicella Vaccine Sales 2017-2022 (K Units)
Figure 28. APAC Live Attenuated Varicella Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. Europe Live Attenuated Varicella Vaccine Sales 2017-2022 (K Units)
Figure 30. Europe Live Attenuated Varicella Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Live Attenuated Varicella Vaccine Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Live Attenuated Varicella Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Americas Live Attenuated Varicella Vaccine Sales Market Share by Country in 2021
Figure 34. Americas Live Attenuated Varicella Vaccine Revenue Market Share by Country in 2021
Figure 35. United States Live Attenuated Varicella Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Live Attenuated Varicella Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Live Attenuated Varicella Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Live Attenuated Varicella Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Live Attenuated Varicella Vaccine Sales Market Share by Region in 2021
Figure 40. APAC Live Attenuated Varicella Vaccine Revenue Market Share by Regions in 2021
Figure 41. China Live Attenuated Varicella Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Live Attenuated Varicella Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Live Attenuated Varicella Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Live Attenuated Varicella Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Live Attenuated Varicella Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Live Attenuated Varicella Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Live Attenuated Varicella Vaccine Sales Market Share by Country in 2021
Figure 48. Europe Live Attenuated Varicella Vaccine Revenue Market Share by Country in 2021
Figure 49. Germany Live Attenuated Varicella Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Live Attenuated Varicella Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Live Attenuated Varicella Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Live Attenuated Varicella Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Live Attenuated Varicella Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Live Attenuated Varicella Vaccine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Live Attenuated Varicella Vaccine Revenue Market Share by Country in 2021
Figure 56. Egypt Live Attenuated Varicella Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Live Attenuated Varicella Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Live Attenuated Varicella Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Live Attenuated Varicella Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Live Attenuated Varicella Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Live Attenuated Varicella Vaccine in 2021
Figure 62. Manufacturing Process Analysis of Live Attenuated Varicella Vaccine
Figure 63. Industry Chain Structure of Live Attenuated Varicella Vaccine
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)